Login / Signup

Disparities in Genetic Testing for Neurologic Disorders.

Aaron BaldwinJuliette CopelandMeron AzageLaynie DratchKelsey JohnsonRachel A PaulDefne A AmadoMichael BaerAndres DeikLauren B ElmanMichael H GuoAli G HamedaniDavid John IrwinAaron LaskerJennifer L Orthmann-MurphyColin C QuinnThomas Francis TropeaStephen W SchererRussell Taki ShinoharaRoy H HamiltonColin A Ellis
Published in: Neurology (2024)
We observed unequal utilization of our clinical neurogenetics program for patients from marginalized and minoritized demographic groups, especially Black patients. Among patients who do undergo evaluation, all groups benefit similarly from genetic testing when it is indicated. Understanding and removing barriers to accessing genetic testing will be essential to health care equity and optimal care for all patients with neurologic disorders.
Keyphrases
  • end stage renal disease
  • healthcare
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • palliative care
  • affordable care act
  • pain management
  • health insurance